3 Australian Penny Stocks With Stronger Balance Sheets

Inflation worries, shifting central bank policies and choppy energy prices are keeping markets on edge, while many large caps already trade on rich valuations. That is where the Financially Fit Penny Stocks screener can help. It filters for lower priced stocks under 5 that still show healthier balance sheets than many early stage peers. This combination can appeal if you want exposure to smaller companies without taking on the weakest financial profiles. In this article, you will see three of the most interesting stocks from the screener that merit a closer look for further research.

Ora Banda Mining (ASX:OBM)

Overview: Ora Banda Mining is an Australian resources company focused on exploring, developing and operating gold and other mineral projects, with its core asset being the 100% owned Davyhurst Gold Project north west of Kalgoorlie.

Operations: Ora Banda Mining currently generates all of its A$554.1 million in revenue from gold production and exploration activities in Australia.

Market Cap: A$2.19b

Ora Banda Mining stands out in this penny stock screener because it couples strong reported profitability with meaningful mine growth. Earnings growth has been very large in recent years, net margins sit above 40% and return on equity is close to 60%, while the stock trades at a lower P/E than many metals and mining peers and at a steep discount to Simply Wall St’s estimated cash flow value. On the ground, the Davyhurst resource and reserve base has been lifted sharply in 2026 and drilling is targeting further upgrades. In addition, the DRIVE to 300 plan and Little Gem prospect work point to a larger production profile. Investors do need to watch the reliance on non cash earnings and external borrowing, which makes understanding true cash returns more important.

Ora Banda Mining’s rapid earnings surge and lower P/E raise an obvious question: Is the current pricing missing a bigger shift in the business? Get the full story in the 4 key rewards and 1 important major warning sign

DroneShield (ASX:DRO)

Overview: DroneShield develops and sells counter drone hardware and software that detects, tracks and disrupts hostile or unauthorised drones, serving defence, intelligence, critical infrastructure and major event customers across multiple regions.

Operations: DroneShield generates all of its A$216.8 million in revenue from its aerospace and defense activities, with A$194.99 million attributed to Australia and the rest of the world and A$29.73 million from the USA after group eliminations.

Market Cap: A$1.57b

DroneShield is shifting from a one off gadget supplier to a repeat defence contractor as counter drone systems become a permanent line item in security budgets. The company has recently become profitable with what appear to be high quality earnings. Order momentum includes A$23.2 million of European defence contracts and World Cup related deployments that show its products operating in real world settings. At the same time, the shares trade below Simply Wall St’s estimated cash flow value, even though the P/S ratio remains elevated, which keeps valuation debate active. Investors need to weigh funding risk from reliance on external borrowing and the relatively new board and management team. A key consideration is how these strengths and weaknesses balance out as larger multi year contracts develop.

DroneShield’s shift toward recurring defence contracts is gaining traction, while the stock still sits below estimated cash flow value. See how the analyst forecasts for DroneShield tie into that valuation gap and what could change it next.

Sigma Healthcare (ASX:SIG)

Overview: Sigma Healthcare is an Australian pharmaceutical wholesaler and retail pharmacy franchisor that supplies medicines and health products to community pharmacies, supports banner groups like Chemist Warehouse, Amcal and Discount Drug Stores, and also sells through online channels.

Operations: Sigma Healthcare generates A$9.55b in revenue from healthcare activities, with A$9.16b from Australia and A$389.79m from international markets.

Market Cap: A$33.82b

Sigma Healthcare gives you exposure to the essential pharmacy supply chain, with earnings that have grown 30.8% a year over the past 5 years and analyst forecasts pointing to further earnings and revenue growth that are both ahead of the broader Australian market. At the same time, the stock trades on a high P/E and net margins have moved from 11.5% to 6.3%. This raises fair questions about how sustainable recent profitability is. In addition, the company has 100% reliance on external borrowing and a relatively new board and management team. Together, these factors create a mix of growth potential and governance risk that may warrant closer attention before the next earnings update at the end of August 2026.

Sigma Healthcare’s earnings growth and premium P/E suggest investors may be missing something in the story. See how the analyst forecasts for Sigma Healthcare stack up against those thinner margins and what that could signal next

The three stocks covered here are just a starting sample, while the full screener surfaces 401 more companies with equally compelling financial profiles and narratives inside the Financially Fit Penny Stocks screener. Use Simply Wall St to identify and analyze the specific catalysts and storylines that matter most to you so you can focus on the highest conviction opportunities in this corner of the market.

Take Control of Your Investment Journey

If DroneShield or any of these companies have caught your attention, register for FREE with Simply Wall St and add your companies to a Watchlist to monitor the share price against the fair value and track any new developments as they happen. Once you've made your move, manage your holdings with our Portfolio Command Center that filters out the noise to deliver only the most critical, actionable updates. Throughout your journey, our Community allows you to filter the best ideas from thousands of investor perspectives. By uncovering hidden catalysts and risks early, you'll accelerate your decision-making and stay one step ahead of the market.

Seeking Fresh Alternatives Before They Fly

Fresh ideas move first. Stocks with real momentum often break out before most investors even notice. Do not wait until prices are flying and stories feel crowded; act now.

• Spot early financial resilience before it becomes obvious and scan a curated list of solid balance sheet and fundamentals (19 results) that could hold up when weaker balance sheets start dropping.
• Ride structural shifts in energy and materials and review the curated 88 nuclear energy infrastructure stocks that may benefit if infrastructure spending gains fresh momentum.
• Target cash generating AI opportunities and track the under the radar for now 70 profitable AI stocks that aren't just burning cash before crowded trades catch up and compress the easy upside.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com